Company: LIMN
Filing Date: 2025-01-16
Form Type: POS AM
Source: 0001104659-25-003835
Chunk: 791

Company: Liminatus Pharma, Inc.
Filing Date: 2025-01-16
Form: POS AM
Chunk 791
---
1.4 .

“

#### Effectiveness Deadline
” shall have the meaning given in subsection 2.1.1 .

“

#### Equity PIPE Subscribers
” shall have the meaning given in the Preamble.

<div align='center'>H-2</div>

TABLE OF CONTENTS

“

#### Equity Subscription Agreement
” shall have the meaning given in the Recitals.

“

#### Exchange Act
” shall mean the Securities Exchange Act of 1934, as it may be amended from time to time.

“

#### Filing Deadline
” shall have the meaning set forth in subsection 2.1.1 .

“

#### Form S-1 Shelf
” shall have the meaning given in subsection 2.1.1 .

“

#### Form S-3 Shelf
” shall have the meaning given in subsection 2.3 .

“

#### Holder
” and “

#### Holders
” shall have the meaning given in the Preamble.

“

#### Insider Letter
” shall mean that certain letter agreement, dated as of the date hereof, by and among the Company, the Sponsor and each of the Company’s officers, directors, director nominees and advisors.

“

#### Liminatus
” shall have the meaning given in the Recitals.

“

#### Liminatus Members
” shall have the meaning given in the Preamble.

“

#### Liminatus Merger Sub
” shall have the meaning given in the Recitals.

“

#### Lock-up Period
” shall mean, with respect to 1/3 of the Lock-up Shares the period ending on the date that is 6 months following the Closing (as defined in the Transaction Agreement), with respect to an additional 1/3 of the Lock-up Shares, the period ending on the date that is 12 months following the Closing, and with respect to the remainder of the Lock-up Shares, the period ending on the date that is 24 months following the Closing; provided that the Lock-up Period shall immediately end on (x) the date on which the VWAP of the Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 Trading Days within any 30-Trading Day period or (y) the date on which the Company completes a liquidation, merger, capital stock exchange, reorganization or other similar transaction that results in all of the Company’s stockholders having the right to exchange their shares of Common Stock for cash, securities or other